Time trends in systemic adjuvant treatment of early-stage node-negative breast cancer in Quebec

被引:0
|
作者
Hébert-Croteau, N
Brisson, J
Latreille, J
Gariépy, G
机构
关键词
D O I
10.1016/S0959-8049(97)89223-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P5
引用
收藏
页码:S15 / S16
页数:2
相关论文
共 50 条
  • [1] Time trends in systemic adjuvant treatment for node-negative breast cancer
    Hébert-Croteau, N
    Brisson, J
    Latreille, J
    Gariépy, G
    Blanchette, C
    Deschênes, L
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) : 1458 - 1464
  • [2] Systemic adjuvant treatment for premenopausal node-negative breast cancer
    Castiglione-Gertsch, M
    Gelber, RD
    O'Neill, A
    Coates, AS
    Goldhirsch, A
    EUROPEAN JOURNAL OF CANCER, 2000, 36 (04) : 549 - 550
  • [3] Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer
    Oguz, Arzu
    Keskin, Gul Sema
    Colak, Dilsen
    Altundag, Ozden
    Akcali, Zafer
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) : 639 - +
  • [4] SYSTEMIC ADJUVANT THERAPY FOR NODE-NEGATIVE BREAST-CANCER
    GEGGIE, PHS
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1989, 141 (10) : 1029 - 1029
  • [5] Adjuvant systemic therapy for women with node-negative breast cancer
    Ginsburg, AD
    Levine, MN
    Bowman, DM
    Olivotto, IA
    Fields, LA
    Little, CD
    Cantin, J
    McGregor, M
    Goldhirsch, A
    Bramwell, V
    Gelmon, K
    Bryce, C
    Allan, S
    Norris, B
    Latreille, J
    Paterson, ADH
    Tomiak, E
    Tremblay, G
    Baird, R
    Becker, P
    Butts, C
    Dancey, JT
    Goel, R
    Kvern, B
    Milne, C
    Narod, S
    Nolan, E
    Thurlow, WH
    Wong, R
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1998, 158 : S43 - S51
  • [6] SYSTEMIC ADJUVANT THERAPY FOR NODE-NEGATIVE BREAST-CANCER
    GINSBURG, AD
    PERRAULT, DJ
    PRITCHARD, KI
    BROWMAN, GP
    MCCULLOCH, PB
    SKILLINGS, J
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1989, 141 (05) : 381 - 387
  • [7] Adjuvant treatment in node-negative, postmenopausal breast cancer
    Hutchins, LF
    Arick, CL
    CANCER INVESTIGATION, 2001, 19 (07) : 706 - 722
  • [8] How Much Is Oncotype DX Recurrence Score Impacting the Adjuvant Treatment Management of Node-Negative Early-Stage Breast Cancer Patients?
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    LABORATORY INVESTIGATION, 2013, 93 : 59A - 59A
  • [9] Treatment of Lymph Node-Negative, Early-Stage HER2-Positive Breast Cancer Reply
    O'Sullivan, Ciara C.
    Holmes, Eileen
    Campbell, Christine
    Bradbury, Ian
    Zujewski, Jo Anne
    Gelber, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (06) : 640 - +
  • [10] How Much Is Oncotype DX Recurrence Score Impacting the Adjuvant Treatment Management of Node-Negative Early-Stage Breast Cancer Patients?
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    MODERN PATHOLOGY, 2013, 26 : 59A - 59A